Added10-Q 2026-11-03 vs 10-K 2026-03-02
There have been no material changes to the risk factors as disclosed in our 2025 10-K.
UNHUnitedHealth Group
UnitedHealth Group Incorporated is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone. 10-K, Item 1
- Employees
- 390,000
- Headquarters
- Eden Prairie, MN
- CEO
- Stephen J. Hemsley
- Next results
- around Jan 26, 2027
5 paragraphs in Risk Factors of the 10-K filed Mar 2, 2026 with nothing like them in the 10-K filed Feb 27, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.
Compared with the Risk Factors in the latest 10-K of the other 59 Health care companies: a paragraph with at least half its words the same at another company is called similar, and the companies are listed under it. A paragraph most of them have is marked boilerplate. No line means no other company has one like it. This counts text; it does not say how serious a risk is.
The risks and uncertainties discussed below are not the only risks we may face. There may be risks and uncertainties not currently known to us or that we may deem to be immaterial that could materially and adversely affect our business, results of operations, financial position, cash flows and prospects.
Similar paragraph at 9 of 59 other Health care companies: BDX, CAH, COO, DVA, HCA, ILMN, ISRG, LLY and 1 moreRead in the 10-K ↗
In addition, our success in the health care marketplace and future growth depends on our ability to develop and deliver innovative and potentially disruptive products and services to satisfy evolving market demands. If we do not continue to
Read in the 10-K ↗
Our increasing use of AI presents legal, regulatory and business risks to our operations, reputation and financial results.
Similar paragraph at 1 of 59 other Health care companies: MCKRead in the 10-K ↗
regulations regarding the receipt or disclosure of rebates and other fees from pharmaceutical companies, the development and use of formularies and other utilization management tools, the use of average wholesale prices or other pricing benchmarks, pricing for specialty pharmaceuticals, limited access to networks, and pharmacy network reimbursement methodologies.
Read in the 10-K ↗
We increasingly rely on new and evolving technologies, including those powered by or incorporating AI, as part of our internal operations and in the delivery of our products and services. AI technologies are subject to evolving and uncertain U.S. federal, state, and international laws and regulations. Emerging requirements may impose new compliance obligations, increase operating costs, or limit certain uses of AI.
Read in the 10-K ↗
New in the latest 10-Q
2 paragraphs in the 10-Q filed Nov 3, 2026 with nothing like them in the 10-Q filed Aug 10, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.
Financial statements and notes
Gains and losses on portfolio actions were recorded within operating costs on the Condensed Consolidated Statements of Operations.
Read in the 10-Q ↗
Gains Losses September 30, 2026 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Debt securities - available-for-sale: U.S. government and agency obligations $ 3,416 $ — $ (256) $ 3,160 State and municipal obligations 5,169 1 (466) 4,704 Corporate obligations 29,627 38 (1,447) 28,218 U.S. agency mortgage-backed securities 12,134 — (1,256) 10,878 Non-U.S. agency mortgage-backed securities 3,495 — (167) 3,328 Total debt securities - available-for-sale 53,841 39 (3,592) 50,288 Debt securities - held-to-maturity: U.S. government and agency obligations 445 — (3) 442 State and municipal obligations 25 — (4) 21 Corporate obligations 3 — — 3 Total debt securities - held-to-maturity 473 — (7) 466 Total debt securities $ 54,314 $ 39 $ (3,599) $ 50,754 December 31, 2025 Debt securities - available-for-sale: U.S. government and agency obligations $ 4,086 $ 2 $ (156) $ 3,932 State and municipal obligations 6,533 24 (232) 6,325 Corporate obligations 25,927 159 (540) 25,546 U.S. agency mortgage-backed securities 10,284 33 (598) 9,719 Non-U.S. agency mortgage-backed securities 2,748 11 (99) 2,660 Total debt securities - available-for-sale 49,578 229 (1,625) 48,182 Debt securities - held-to-maturity: U.S. government and agency obligations 461 2 (1) 462 State and municipal obligations 26 — (2) 24 Corporate obligations 3 — — 3 Total debt securities - held-to-maturity 490 2 (3) 489 Total debt securities $ 50,068 $ 231 $ (1,628) $ 48,671
Read in the 10-Q ↗
The 10-Q's risk factors against the 10-K
Item 1A of the 10-Q filed Nov 3, 2026 against Item 1A of the 10-K filed Mar 2, 2026.
A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed.
Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed,
Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal
(cut words struck through, new words highlighted and underlined).
Text on the page, not a score; each links to the filing at sec.gov.
Reworded10-Q 2026-11-03 vs 10-K 2026-03-02
Reworded10-Q 2026-11-03 vs 10-K 2026-03-02
The risks and uncertainties discussed below described in our 2025 10-K are not the only risks we may face. facing us.
Work on UNH in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/UNH/export.csv") into a cell.